Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes
NCT01684956
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Interventions
PROCEDURE:
Intradermal injection
PROCEDURE:
Subcutaneous injection
Sponsor
Massachusetts General Hospital